AHZANTIVE
- Product NDC
- 85006-2908
- 11-digit product format
- 850062908
- Labeler code
- 85006
- Product ID
- 85006-2908_42277606-719f-1fd3-e063-6394a90ad9d6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aflibercept-mrbb
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Valorum Biologics, LLC
- Application
- BLA761378
- Marketing category
- BLA
- Marketing start
- 2024-06-01
- Substance
- AFLIBERCEPT-MRBB
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AHZANTIVE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AFLIBERCEPT-MRBB | 40 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 15C2VL427D |
| Rxcui | 2706533, 2706541 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 85006-2908-1 | AHZANTIVE | 0.05 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 0.05 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 85006-2908 | AHZANTIVE (AFLIBERCEPT-MRBB) INJECTION, SOLUTION [VALORUM BIOLOGICS INC] | 3 | Current NDC, 1 package rows | 20250328_289e4b90-f741-c0f6-e063-6394a90a2068.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 85006-2908-1 | 85006290801 | .05 mL in 1 VIAL, SINGLE-DOSE (85006-2908-1) | 2025-10-24 | No | No | Historical |